Guardant Health share price today

(GH)

Guardant Health share price is $34.76 & ₹2,946.29 as on 14 Dec 2024, 2.30 'hrs' IST

$34.76

▲

-0.18

(-0.52%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Guardant Health share price in Dollar and Rupees. Guide to invest in Guardant Health from India. Also see the sentimental analysis on Indian investors investing in Guardant Health. Get details on the Indian mutual funds that are investing in Guardant Health. Get Analyst recommendations and forecasts along with all the Guardant Health's financials.

Guardant Health share price movements

$34.31
$35.08
$34.76
1.31%
Downside
Day's Volatility :2.21%
Upside
0.91%
$15.81
$38.53
$34.76
54.52%
Downside
52 Weeks Volatility :58.97%
Upside
9.78%

Guardant Health Returns

Period	Guardant Health, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	37.67%	-9.7%	0.0%
6 Months	14.56%	-3.4%	0.0%
1 Year	23.94%	3.7%	0.0%
3 Years	-63.81%	3.8%	-18.9%

Guardant Health Key Statistics

in dollars & INR

Previous Close	$34.94
Open	$35.0
Today's High	$35.0801
Today's Low	$34.305
Market Capitalization	$4.4B
Today's Volume	$1.5M
52 Week High	$38.53
52 Week Low	$15.81
Revenue TTM	$692.3M
EBITDA	$-386.3M
Earnings Per Share (EPS)	$-4.28
Profit Margin	-74.02%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-609.28%

How to invest in Guardant Health from India?

It is very easy for Indian residents to invest directly in Guardant Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Guardant Health stock in both rupees (INR) and dollars (USD). Search for Guardant Health or GH on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Guardant Health or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Guardant Health shares which would translate to 0.024 fractional shares of Guardant Health as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Guardant Health

-69%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Guardant Health on INDmoney from India has reduced in the last 30 days as on Dec 14, 2024. -69% less investors are searching Guardant Health in the last 30 days versus the previous period.

Global Institutional Holdings in Guardant Health

Vanguard Group Inc
9.47%
BlackRock Inc
9.10%
Wellington Management Company LLP
8.20%
Cadian Capital Management LP
5.61%
Deep Track Capital, LP
4.86%
Baillie Gifford & Co Limited.
4.75%

Analyst Recommendation on Guardant Health

Buy

83%Buy

16%Hold

0%Sell

Based on 30 Wall street analysts offering stock ratings for Guardant Health(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Guardant Health

What analysts predicted

Upside of 23.71%

Current:

$34.76

Target:

$43.00

Insights on Guardant Health

Price Movement
In the last 7 days, GH stock has moved down by -5.2%
Increasing Revenue
Revenue is up for the last 11 quarters, 96.09M → 191.47M (in $), with an average increase of 6.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -102.62M → -107.75M (in $), with an average decrease of 5.0% per quarter
GH vs A (3 yr)
In the last 3 years, Guardant Health, Inc. has experienced a drawdown of -62.9%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 53.1%

Guardant Health Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$90.6M	↑ 81.85%
Net Income	$-85.1M	↑ 2.21%
Net Profit Margin	-93.85%	↑ 73.12%

	FY19	Y/Y Change
Revenue	$214.4M	↑ 136.52%
Net Income	$-67.9M	↓ 20.23%
Net Profit Margin	-31.65%	↑ 62.2%

	FY20	Y/Y Change
Revenue	$286.7M	↑ 33.75%
Net Income	$-246.3M	↑ 262.98%
Net Profit Margin	-85.89%	↓ 54.24%

	FY21	Y/Y Change
Revenue	$373.7M	↑ 30.32%
Net Income	$-384.8M	↑ 56.23%
Net Profit Margin	-102.98%	↓ 17.09%

	FY22	Y/Y Change
Revenue	$449.5M	↑ 20.31%
Net Income	$-654.6M	↑ 70.12%
Net Profit Margin	-145.61%	↓ 42.63%

	FY23	Y/Y Change
Revenue	$563.9M	↑ 25.45%
Net Income	$-479.4M	↓ 26.76%
Net Profit Margin	-85.02%	↑ 60.59%

	Q2 FY23	Q/Q Change
Revenue	$137.2M	↑ 6.55%
Net Income	$-72.8M	↓ 45.5%
Net Profit Margin	-53.06%	↑ 50.68%

	Q3 FY23	Q/Q Change
Revenue	$143.0M	↑ 4.29%
Net Income	$-86.1M	↑ 18.32%
Net Profit Margin	-60.2%	↓ 7.14%

	Q4 FY23	Q/Q Change
Revenue	$155.1M	↑ 8.41%
Net Income	$-187.0M	↑ 117.23%
Net Profit Margin	-120.63%	↓ 60.43%

	Q1 FY24	Q/Q Change
Revenue	$168.5M	↑ 8.67%
Net Income	$-115.0M	↓ 38.52%
Net Profit Margin	-68.24%	↑ 52.39%

	Q2 FY24	Q/Q Change
Revenue	$177.2M	↑ 5.19%
Net Income	$-102.6M	↓ 10.75%
Net Profit Margin	-57.91%	↑ 10.33%

	Q3 FY24	Q/Q Change
Revenue	$191.5M	↑ 8.04%
Net Income	$-107.8M	↑ 4.99%
Net Profit Margin	-56.28%	↑ 1.63%

	FY18	Y/Y Change
Profit	$47.4M	↑ 160.26%

	FY19	Y/Y Change
Profit	$143.7M	↑ 202.88%

	FY20	Y/Y Change
Profit	$194.2M	↑ 35.18%

	FY21	Y/Y Change
Profit	$250.7M	↑ 29.12%

	FY22	Y/Y Change
Profit	$293.2M	↑ 16.94%

	FY23	Y/Y Change
Profit	$336.9M	↑ 14.9%

	Q2 FY23	Q/Q Change
Profit	$83.3M	↑ 10.13%

	Q3 FY23	Q/Q Change
Profit	$85.4M	↑ 2.54%

	Q4 FY23	Q/Q Change
Profit	$236.2M	↑ 176.52%

	Q1 FY24	Q/Q Change
Profit	$103.2M	↓ 56.31%

	Q2 FY24	Q/Q Change
Profit	$104.8M	↑ 1.57%

	Q3 FY24	Q/Q Change
Profit	$117.0M	↑ 11.61%

	FY18	Y/Y Change
Operating Cash Flow	$-72.2M	↓ 0.07%
Investing Cash Flow	$-153.0M	↓ 10.2%
Financing Cash Flow	$293.2M	↑ 4.08%

	FY19	Y/Y Change
Operating Cash Flow	$-47.1M	↓ 34.7%
Investing Cash Flow	$-317.6M	↑ 107.52%
Financing Cash Flow	$367.3M	↑ 25.29%

	FY20	Y/Y Change
Operating Cash Flow	$-103.9M	↑ 120.49%
Investing Cash Flow	$-617.1M	↑ 94.31%
Financing Cash Flow	$1.4B	↑ 283.96%

	FY21	Y/Y Change
Operating Cash Flow	$-209.0M	↑ 101.12%
Investing Cash Flow	$-63.2M	↓ 89.77%
Financing Cash Flow	$-66.8M	↓ 104.74%

	FY22	Y/Y Change
Operating Cash Flow	$-309.5M	↑ 48.06%
Investing Cash Flow	$149.8M	↓ 337.22%
Financing Cash Flow	$-189.1M	↑ 182.97%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-94.0M	↑ 26.29%
Investing Cash Flow	$-241.1M	↓ 253.37%
Financing Cash Flow	$383.9M	↓ 45047.78%

Guardant Health Technicals Summary

Sell

Neutral

Buy

Guardant Health is currently in a neutral trading position according to technical analysis indicators.

Guardant Health Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Guardant Health, Inc.	10.53%	14.56%	23.94%	-63.81%	-54.42%
Idexx Laboratories, Inc.	1.71%	-13.31%	-19.2%	-28.51%	71.13%
Agilent Technologies Inc.	4.94%	6.89%	3.02%	-8.68%	66.86%
Thermo Fisher Scientific, Inc.	-3.12%	-7.57%	1.35%	-19.94%	63.32%
Danaher Corp.	-2.91%	-7.72%	3.2%	-25.55%	54.85%
Iqvia Holdings Inc.	-5.27%	-6.07%	-11.62%	-25.26%	36.74%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Guardant Health, Inc.	NA	NA	NA	-2.01	-6.09	-0.16	NA	-0.49
Idexx Laboratories, Inc.	42.19	42.19	4.6	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	31.88	31.88	2.39	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	33.57	33.57	2.04	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	44.42	44.42	3.14	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.47	26.47	1.04	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Guardant Health, Inc.	Buy	$4.4B	-54.42%	NA	-74.02%
Idexx Laboratories, Inc.	Buy	$35.8B	71.13%	42.19	22.53%
Agilent Technologies Inc.	Buy	$40.3B	66.86%	31.88	21.75%
Thermo Fisher Scientific, Inc.	Buy	$204.4B	63.32%	33.57	14.48%
Danaher Corp.	Buy	$170.0B	54.85%	44.42	16.39%
Iqvia Holdings Inc.	Buy	$36.5B	36.74%	26.47	9.17%

Guardant Health Dividend announcements

Guardant Health Earnings
Guardant Health’s price-to-earnings ratio stands at None
Read More

About Guardant Health

we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.

Organization	Guardant Health
Employees	1768
CEO	Dr. Helmy Eltoukhy Ph.D.
Industry	Health Services

Management People of Guardant Health

Name	Title
Dr. Helmy Eltoukhy Ph.D.	Co-Founder, Co-CEO & Chairman
Dr. AmirAli Talasaz Ph.D.	Co-CEO & Director
Mr. Michael Bell	Chief Financial Officer
Ms. Darya Chudova	Chief Technology Officer
Dr. Craig Eagle M.D.	Chief Medical Officer
Mr. Christopher Freeman	Chief Commercial Officer
Mr. Kumud Kalia	Chief Information Officer
Zarak Khurshid	Vice President of Investor Relations
Mr. John G. Saia J.D.	Chief Legal Officer & Corporate Secretary
Ms. Jennifer Higgins	Senior Vice President of Public Affairs

Important FAQs about investing in Guardant Health from India :

What is Guardant Health share price today?

Guardant Health share price today stands at $34.76, Open: $35.00 ; Previous Close: $34.94 ; High: $35.08 ; Low: $34.31 ; 52 Week High: $38.53 ; 52 Week Low: $15.81. The stock opens at $35.00, after a previous close of $34.94. The stock reached a daily high of $35.08 and a low of $34.31, with a 52-week high of $38.53 and a 52-week low of $15.81.

Can Indians buy Guardant Health shares?

Yes, Indians can invest in the Guardant Health (GH) from India.

With INDmoney, you can buy Guardant Health at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Guardant Health at zero transaction cost.

How can I buy Guardant Health shares from India?

It is very easy to buy Guardant Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Guardant Health be purchased?

Yes, you can buy fractional shares of Guardant Health with INDmoney app.

What are the documents required to start investing in Guardant Health stocks?

To start investing in Guardant Health, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.